11 pending office actions • 8 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Dihesys Digital Health Systems GmbH | 3 |
| Qanatpharma AG | 2 |
| Vandewater Capital Holdings, LLC | 1 |
| Gbiotech S.À.R.L. | 1 |
| Aphaia Ip AG | 1 |
| Imophoron Limited | 1 |
| Nemera La Verpillière | 1 |
| UNIVERSITAET ZUERICH | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18801045 | Canopy For Climate And Solar Mitigation | Vandewater Capital Holdings, LLC | CAMBY, RICHARD M | 3661 | Non-Final OA | Aug 12, 2024 |
| 18258742 | Method For Producing Patient-Optimised Dosage Forms | Dihesys Digital Health Systems GmbH | LIPPERT, JOHN WILLIAM | 1615 | Non-Final OA | Oct 12, 2023 |
| 18002461 | Fatty Acid Complexes Of Coronavirus Spike Protein And Their Use | Gbiotech S.À.R.L. | FISHER, MELISSA L | 1658 | Non-Final OA | Dec 19, 2022 |
| 17783818 | Dot Printing Method And Device For Additive Manufacturing Of Dosage Forms Which Contain Active Substances | Dihesys Digital Health Systems GmbH | GROUX, JENNIFER LILA | 1754 | Non-Final OA | Dec 14, 2022 |
| 18001582 | Pharmaceutical Compositions Containing Enterokine Releasing Substances In Multiple Dosage Forms In Combination With Gelling Agents | Aphaia Ip AG | NGUYEN, JOHN P | 1619 | Final Rejection | Dec 12, 2022 |
| 17797941 | Engineered Polypeptides Derived From Variable Domain of Adenovirus Penton Base | Imophoron Limited | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | Non-Final OA | Aug 05, 2022 |
| 17780353 | Device For Inserting A Needle | Nemera La Verpillière | WITTLIFF, KATERINA ANNA | 3783 | Non-Final OA | May 26, 2022 |
| 17639113 | Minimal Messenger RNAs and uses thereof | UNIVERSITAET ZUERICH | MCLEOD, AFRICA MHAIRIE | 1635 | Non-Final OA | Feb 28, 2022 |
| 17615450 | Pharmaceutical Dosage Forms and Method For Their Production | Dihesys Digital Health Systems GmbH | LIPPERT, JOHN WILLIAM | 1615 | Non-Final OA | Nov 30, 2021 |
| 17274773 | Use of Casein Kinase 1 Inhibitors For Treating Vascular Diseases | Qanatpharma AG | RAMOS LEWIS, JOSMALEN MILAGROS | 1621 | Non-Final OA | Mar 09, 2021 |
| 17274726 | Use of CFTR Modulators For Treating Cerebrovascular Conditions | Qanatpharma AG | DRAPER, LESLIE A ROYDS | 1629 | Final Rejection | Mar 09, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial